Will additional funding for pharmacies prove to be a prescription for success?

A £645 million cash injection for England's community pharmacies is a welcome step but may fall short of being a cure-all for the sector’s many problems, warns Beth Kennedy

C+D editor Beth Kennedy
Beth Kennedy: "The lack of detail in the proposals leaves me feeling slightly wary"

If you’ve been left reeling from yesterday’s news that the government has finally stumped up additional funding for community pharmacies, then you’re not the only one.

Months, if not years, of pleas for the government to invest more money into pharmacy had until then fallen on deaf ears, rejected due to the constraints of a five-year deal that was agreed well before a global pandemic and rampant inflation took its toll on the sector. So imagine my surprise to hear that an impressive £645m cash injection is on its way.

Read more: Government injects £645m investment into community pharmacy

An upcoming Pharmacy First service covering the whole of England, the existing pharmacy contraceptive and the hypertension case-finding services are set to benefit from the funding pot, although it is as yet unclear how the money will be divided between the services.

First things first, I think it’s time to celebrate. The announcement marks the culmination of months of hard work by pharmacy organisations in lobbying for better funding, and it’s wonderful to see such a sizeable investment being made.

Read more: ‘Devil in the detail’: Sector cautiously welcomes plan to expand services

While I don't want to look a gift horse in the mouth, I must admit that the lack of detail in the proposals leaves me feeling slightly wary. The Pharmaceutical Services Negotiating Committee (PSNC) and the government are now entering into “detailed negotiations” about how the money will be spent, and I’m firmly with pharmacy bodies in reserving my judgement until those are complete.

While additional funding for clinical services is more than welcome, it does not do enough to address other fundamental issues affecting the community pharmacy sector – such as workforce retention and a broken medicines reimbursement system that is leaving thousands of contractors dispensing at a loss.

Read more: Why a chat with the PM has given me hope for community pharmacy's future

These are certainly problems that require their own attention, and I hope that Rishi Sunak’s government will decide to address them in the near future. With a general election looming on the horizon, we can only hope his party will see the promise of a strong community pharmacy network as a vote winner.

Beth Kennedy is the editor of C+D

Sign in or register for free

Latest from Opinion

Why I’ve launched a campaign against the RPS’s planned changes

 
• By 
 • comment

‘Vote no’ campaigner Martin Astbury tells C+D why he believes the RPS plans for change represent a shift away from pharmacist leadership and why members should vote against them this week…

CPE is negotiating in a very difficult and nuanced environment that few will have experienced

 
• By 
 • comment

I also read comments that CPE does not appreciate this critical position, and I fundamentally refute that. Knowing the colleagues, both elected and employed, at CPE as I do, this is far from the case.

It’s not just funding delays holding pharmacy back, it’s the old dinosaurs too...

 
• By 
 • comment

Community pharmacy is risk adverse, considered, and dare I say it, conservative. But, when it comes to the survival of pharmacy, we can’t afford to let the fear of change – or those resistant to it - hold us back.

More from Analysis

The steady evolution of pharmacy technicians into the future

 
• By 
 • comment0

How has the role of a pharmacy technician been professionalised, and what's their place within community pharmacy’s future?

analysis

Salary Survey – Are you satisfied with your salary?

  • comment2

C+D’s annual Salary Survey covers many angles, but of course your salary is one of them. Are you getting the satisfaction you need?